Release Date: 25/02/14 18:25 Summary: Interim Results 2014 and Fund Update Price Sensitive: No Download Document 318.26KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%